Join
Live feed
·
PRReleasevia Quantisnow
Tempus AI Inc. logo

Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases

ByQuantisnow·Wall Street's wire, on your screen.
TEM· Tempus AI Inc.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEM (Tempus AI Inc.) and more on Quantisnow.